A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Metronidazole Vaginal Gel 1.3% in Adolescent Female Subjects With Bacterial Vaginosis
Phase of Trial: Phase IV
Latest Information Update: 19 May 2017
At a glance
- Drugs Metronidazole (Primary)
- Indications Bacterial vaginosis
- Focus Adverse reactions
- Sponsors Actavis; Allergan
- 17 May 2017 Status changed from active, no longer recruiting to completed.
- 31 Oct 2016 Planned End Date changed from 1 Jun 2017 to 1 Nov 2016.
- 31 Oct 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2016.